170
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in NC/Nga mice

, , , , , , , , , , , , , , , & show all
Pages 2459-2467 | Published online: 20 Oct 2011

References

  • LeungDYBieberTAtopic dermatitisLancet2003361935215116012531593
  • AkdisACAkdisMTrautmannABlaserKImmune regulation in atopic dermatitisCurr Opin Immunol200212664164611102766
  • LeungDYAtopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseaseJ Allergy Clin Immunol19959633023187560632
  • ThaciDLong term management of childhood atopic dermatitis with calcineurin inhibitorsHautarz2003545418423
  • NooriSATopical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded studyComplement Ther Med200311422623415022655
  • TaniguchiYKohnoKInoueSOral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga miceInt Immunopharmacol2003391313132412890429
  • MainardiTKapoorSBieloryLComplementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effectsJ Allergy Clin Immunol2009123228329419203652
  • ChoiSEJeongMSKangMJEffect of topical application and intraperitoneal injection of oregonin on atopic dermatitis in NC/Nga miceExp Dermatol2010198e37e4319849716
  • AsakawaYChemical constituents of Alnus firma (Betulaceae)Bull Chem Soc Japan197043722232229
  • KimJHLeeKWLeeMWLeeHJKimSHSurhYJHirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human epithelial cells: NFkB as a potential molecular targetFEBS Letters2006580238539216380122
  • JooSSKimSGChoiSESuppression of T cell activation by hirsutenone, isolated from the bark of Alnus japonica, and its therapeutic advantages for atopic dermatitisEur J Pharmacol20096141–39810519409888
  • TrottaMPeiraEDebernardiFGallarateMElastic liposomes for skin delivery of dipotassium glycyrrhizinateInt J Pharm2002241231932712100859
  • PaliwalSMitragotriSUltrasound-induced cavitation: applications in drug and gene deliveryExpert Opin Drug Deliv20063671372617076594
  • PrausnitzMRMicroneedles for transdermal drug deliveryAdv Drug Deliv Rev200456558158715019747
  • DubeyVMishraDAsthanaAJainNKTransdermal delivery of a pineal hormone: melatonin via elastic liposomesBiomaterials200627183491349616513163
  • KimYMKimBGKangMJEumJYChoiYWIn vivo skin deposition and photoprotection effect of genistein in liposomal gel formulationsJ Kor Pharm Sci2009385325329
  • BouwstraJAHoneywell-NguyenPLSkin structure and mode of action of vesiclesAdv Drug Deliv Rev20025414155
  • CevcGBlumeGNew, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, TransfersomesBiochim Biophys Acta20011514219120511557020
  • LopesLBFurnishEKomalavilasPEnhanced skin penetration of P20 phosphopeptide using protein transduction domainsEur J Pharm Biopharm200868244144518035527
  • HouYWChanMHHsuHRTransdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptidesExp Dermatol20071612999100618031459
  • RothbardJBGarlingtonSLinQConjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammationNat Med20006111253125711062537
  • NagarsenkerMSLondheVYNadkarmiGDPreparation and evaluation of liposomal formulations of tropicamide for ocular deliveryInt J Pharm19991901637110528098
  • MohammedARWestonNCoombesAGAFitzgeraldMPerrieYLiposome formulation of poorly water soluble drugs: optimization of drug loading and ESEM analysis of stabilityInt J Pharm20042851–2233415488676
  • TouitouEDavanNBergelsonLGodinBEliazMEthosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration propertiesJ Control Release200065340341810699298
  • CevcGGebauerDStieberJSchatzleinABlumeGUltraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amount of insulin across the intact mammalian skinBiochim Biophys Acta1998136822012159459598
  • BerghBAIWertzPWJungingerHEBouwstraJAElasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurementsInt J Pharm20012171–2132411292538
  • LeeJLeeSCAcharyaGChangCJParkJHydrotropic solubilization of paclitaxel: Analysis of chemical structures for hydrotropic propertyPharm Res20032071022103012880288
  • HuailiangWRamachandranCWeinerNDRoessierBJTopical transport of hydrophilic compounds using water-in-oil nanoemulsionsInt J Pharm20012201–2637511376968
  • TaniguchiYKohnoKInoueSOral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga miceInt Immunopharmacol200331313112412890429
  • VestergaardCYoneiyamaHMuraiMOverproduction of Th2- specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesionsJ Clin Invest199910481097110510525048
  • SinghRPGuMAqarwalRSilibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesisCancer Res20086862043205018339887
  • KimYSKimYLeeKJKwonHJKimDSKimTYImprovement of atopic dermatitis in NC/Nga mice by topical application of CpG hosphodiester-ODNInt Arch Allergy Immunol2007144431532417671391
  • VermaDDVermaSBlumeGFahrAParticle size of liposomes influences dermal delivery of substances into skinInt J Pharm20032581–214115112753761
  • KangMJEumJYJeongMSFacilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga miceBiol Pharm Bul2010331100106
  • El MaghrabyGMWilliamsACBarryBWOestradiol skin delivery from ultradeformable liposomes: renement of surfactant concentrationInt J Pharm20001961637410675708
  • CoffmanREKildsigDOHydrotropic solubilization mechanistic studiesPharm Res19961310146014638899835
  • CharmanWNLaiCSCFinninBCReedBLSelf-association of nicotinamide in aqueous solution: mass transport, freezing-point depression, and partition coefficient studiesPharm Res199189114411501838597
  • Honeywell-NguyenPLGoorisGSBouwstraJAQuantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivoJ Invest Dermatol2004123590291015482478
  • LopesLBBrophyCMFurnishEComparative study of the skin penetration of protein transduction domains and a conjugated peptidePharm Res200522575075715906170
  • KuroyanagiMShimomaeMNagashimaYNew diarylheptanoids from Alnus japonica and their antioxidative activityChem Pharm Bull200553121519152316327181
  • MatsudaHWatanabeNGebaGPDevelopment of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga miceInt Immunol1997934614669088984
  • GaoXKFusedaKShibataTTanakaHInagakiNNagaiHKampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice. Evid Based ComplementAlternat Med200522191199
  • TohruSKogisoMMituyaKKomatsuTYamamotoSGenistein suppresses development of spontaneous atopic-like dermatitis in NC/Nga miceJ Nutr Sci Vitaminol200652429329617087057
  • KotaniMMatsumotoMFujitaAPersimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga miceJ Allergy Clin Immunol2000106115916610887319
  • LewisRAAustenKFSobermanRJLeukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseaseN Engl J Med1990323106456552166915
  • ShawRJWalshGMCromwellOMogbellRSpryCJKayABActivated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulationNature198531660241501524010786